The main goal of treatment is to reduce the risk of cardiovascular diseases, such as heart disease and stroke, by lowering blood cholesterol levels. Studies have shown that for every 1% reduction in cholesterol levels there is a 2% reduction in the rate of heart disease. People who benefit most from lowering their cholesterol are those who already have heart disease or who have multiple risk factors for the disease. In addition to lifestyle changes, specific cholesterol-lowering medications are often prescribed.
Changes in lifestyle are the most effective means of both preventing and, in less severe cases, treating elevated LDL cholesterol levels. The cornerstone of this treatment strategy is dietary modification and exercise. In addition to little fat and cholesterol, lean protein (such as soy and fish), and lots of fruits and vegetables, diets should include:
- Soluble fibers, such as psyllium, which have a cholesterol lowering effect
- Soy, which reduces total cholesterol
- Antioxidants, which when consumed in high amounts, have been associated with lowered risk of cardiovascular disease. (Vitamin E appears to be of particular value).
- Omega-3 fatty acids, such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which may lower the chance of recurrent heart attacks and death from heart disease.
- Folic acid supplements, which may improve the function of the blood vessels in those with high cholesterol and reduce the risk of heart disease.
In addition, herbs and supplements may help lower cholesterol levels. The most promising include:
- Red Yeast Rice
- Fenugreek
- Guggulipid
Lifestyle
The following changes in life habits have been shown to both prevent high cholesterol and to lower high levels of cholesterol and triglyceride:
- Dietary changes
- Weight reduction
- Increased physical activity
- Stress reduction
- Quitting smoking (because tobacco use lowers HDL cholesterol)
Medications
According to the National Cholesterol Education Program (NCEP) guidelines, healthcare practitioners should prescribe cholesterol-lowering medication when:
- LDL cholesterol is higher than 190 mg/dL and the person has no known risk factors for heart disease
- LDL cholesterol is higher than 160 mg/dL and the person has two or more risk factors for heart disease
- LDL cholesterol exceeds 130 mg/dL and the person has heart disease
The following are commonly prescribed medications for high cholesterol:
- Statin drugs or HMG-CoA reductase inhibitors (lovastatin, pravastatin, simvastatin, atorvastatin, and fluvastatin). This class of medications is used to treat elevated LDL and triglyceride levels, and also to raise HDL levels. Taking statins reduces the risk of death in those with heart disease and slows the rate of development of both heart disease and stroke when used by those with high cholesterol. Healthcare practitioners prefer statin drugs because they are the most effective cholesterol-lowering medication. Side effects include myositis (inflammation of the muscles), joint pain, stomach upset, and liver damage.
- Niacin (nicotinic acid). This is used to treat elevated LDL and triglyceride levels and is more effective in increasing HDL levels than other cholesterol-lowering medications. Side effects may include redness or flushing of the skin (which can be reduced by taking aspirin 30 minutes before the niacin), stomach upset (which usually subsides in a few weeks), headache, dizziness, blurred vision, and liver damage. Starting with low doses of niacin and increasing very gradually helps to reduce the likelihood and severity of side effects. Niacin should be avoided by people who have gout, diabetes, low blood pressure, or a history of peptic ulcer.
- Bile acid sequestrants (cholestyramine, colestipol, and colesevelam). These are used to treat elevated LDL levels. Common side effects include bloating, constipation, heartburn, and elevated triglycerides. These medications may also lead to a deficiency of fat-soluble vitamins and loss of calcium in the urine.
- Fibric acid derivatives (gemfibrozil, fenofibrate, and clofibrate). These medications are used to treat elevated triglycerides and low HDL in people who cannot tolerate niacin. Side effects include myositis, stomach upset, sun sensitivity, gallstones, irregular heartbeat, and liver damage.
- Probuchol lowers both LDL and HDL. Its use is therefore generally limited to certain types of hereditary high cholesterol and/or to cases in which other cholesterol-lowering medications have been ineffective. Side effects include diarrhea, bloating, nausea, and dizziness.
Nutrition and Dietary Supplements
There is considerable evidence that dietary antioxidants, particularly vitamin E, as well as folic acid, fiber, and soy can help to prevent the development of heart disease. Substances that have shown promise in lowering cholesterol specifically or that have demonstrated benefit in preventing heart disease in people with high cholesterol are discussed below.
Fiber and Fiber Sources
The American Heart Association (AHA) recommends increased intake of dietary fiber in the form of whole grains, vegetables, fruits, legumes, and nuts because they have been shown to do the following:
- Reduce total and LDL cholesterol more effectively than a diet low in saturated fat and cholesterol alone
- Help control weight and intake of calories by promoting a sense of fullness
- Improve cholesterol and triglyceride levels as well as blood sugar in people with diabetes
Soluble fibers such as those in psyllium husk, guar gum, and oat bran have a cholesterol-lowering effect when added to a low-fat, cholesterol-lowering diet. Studies have shown psyllium, in particular, to be quite effective in lowering total as well as LDL cholesterol levels. Oat bran (3 g per day) has also been shown to lower total cholesterol.
Soy
Many studies have shown that replacing some animal protein with soy protein in the diet results in lower blood cholesterol levels, especially when soy is consumed as part of a general low-fat diet. One study has shown that as little as 20 g of soy protein per day is effective in reducing total cholesterol, but that 40 to 50 g shows faster effects (in 3 weeks instead of 6). This evidence suggests that soy protein should be included in a healthy diet. In fact, since October of 1999, the FDA has allowed the labels of foods containing 6.25 g or more of soy protein to carry the claim that these foods reduce the risk of heart disease. Moreover, the AHA recommends that people with elevated total and LDL cholesterol add soy to their daily diet. Ethanol-washed soy preparations should be avoided because this procedure causes the soy to lose its isoflavones (the substances likely responsible for its cholesterol-lowering effects) in the process.
Omega-3 fatty Acids
EPA and DHA
Numerous studies have reported the benefits of consuming fish oils, rich in the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), at doses ranging from 850 mg to 4 g per day for those with heart disease. Supplementation with DHA, for example, has been shown to reduce triglycerides and LDL levels and raise HDL levels.
Alpha-Linolenic Acid
Walnuts are one of the best sources of the omega-3 fatty acid alpha-linolenic acid. Replacing a major portion (35%) of the monounsaturated fat in the Mediterranean diet with walnuts appears to significantly improve cholesterol and triglyceride levels in people with high cholesterol. Almonds, although not as well studied as walnuts, appear to have similar effects when used as a substitute for a portion of monounsaturated fats in low-fat diets.
Vitamin E
A number of studies conducted over the last 10 years have reported beneficial results from the use of vitamin E supplements for the treatment and prevention of heart disease including for those with elevated cholesterol levels.
Vitamin C
Preliminary evidence suggests that vitamin C (3 glasses of orange juice per day or up to 3 g per day as a supplement) may help decrease total and LDL cholesterol and triglycerides, and increase HDL levels.
Coenzyme Q10 (CoQ10)
Coenzyme Q10 (CoQ10), also known as ubiquinone, is an antioxidant that is essential for energy production. Levels of CoQ10 have been found to be lower in people with high cholesterol when they were compared to healthy individuals of the same age. Furthermore, when person with high cholesterol take statin drugs, CoQ10 levels appear to decline in direct proportion to the level of decrease in cholesterol. This is particularly important to bear this in mind when statin drugs are used for long periods of time. Taking CoQ10 supplements, however, can correct the deficiency caused by statin medications without affecting the medication's positive effects on cholesterol levels.
Folic Acid (Vitamin B9)
High blood levels of homocysteine (an amino acid produced by the body) have been shown to increase the risk of heart attacks. Evidence suggests that high homocysteine levels are also related to low folate levels. This means that an adequate supply of folate and other B vitamins may be important, particularly for those with heart disease.
Plant Sterols
Plant sterols (fats present in fruits, vegetables, seeds, and nuts) appear to interfere with the absorption of cholesterol, thereby lowering the level of cholesterol in the blood. A daily intake of 1.6 g of margarine containing plant sterols has been shown to reduce total and LDL cholesterol, with larger intakes not necessarily providing any additional benefit. Questions have been raised, however, regarding the possibility that plant sterols interfere with the absorption of certain antioxidants such as alpha- and beta-carotenes, alpha-tocopherol, and lycopene. While the significance of this is still unclear, it warrants further investigation, and these micronutrients must be carefully monitored in the blood of those using plant sterols.
L-Carnitine
L-carnitine is produced in the liver and kidneys from the amino acids lysine and methionine. It is stored in skeletal muscles and the heart and may be beneficial in treating conditions such as chest pain, heart attack, heart failure, diabetes, and abnormal cholesterol. In several human studies, supplementation with 2 to 3 g per day of L-carnitine led to a significant reduction in total cholesterol and triglycerides, and to increases in HDL cholesterol levels.
Red wine
Red wine contains flavonoids, which inhibit LDL oxidation (the process whereby LDL cholesterol adheres to artery walls). Studies have demonstrated a relationship between flavonoid consumption (from food) and reduced risk of death from coronary heart disease.
Although nonalcoholic grape products contain flavonoids, red wine contains much higher concentrations of flavonoids. However, the use of alcohol is not advocated by the AHA and other organizations because of the potential for addiction and the other serious repercussions such as motor vehicle accidents and the development of hypertension, liver disease, breast cancer, weight gain. If red wine is consumed, it is recommended that men have no more than 2 glasses (20 g ethanol) per day and women, no more than 1 glass (15 g ethanol).
Red Yeast Rice
Red yeast rice, the fermented product of rice and red yeast, has been used in China since at least 800 AD to make wine and preserve food, and for its medicinal properties, which are believed to include, among other things, improvement in blood circulation. Recent well-designed studies have shown that red yeast rice significantly reduces total cholesterol, LDL cholesterol, and triglyceride concentrations.
Chromium
Brewer's yeast is an important source of chromium. Ninety percent of Americans are deficient in this important mineral. Chromium has demonstrated the ability to lower LDL levels in the blood and raise HDL levels.
Calcium
Preliminary studies in animals and people suggest that calcium supplements, in the range of 1,500 to 2,000 mg per day, may help to lower cholesterol. The information available thus far suggests that keeping cholesterol levels normal or even low by using calcium supplements (along with many other measures such as changing your diet and exercising) is likely to be more beneficial than trying to treat it by adding calcium once you already have elevated cholesterol. More research in this area is needed.
Vitamin B5 (Pantothenic Acid)
Research has shown that vitamin B5 lowers cholesterol. Studies are currently underway to determine if this vitamin helps prevent heart disease.
Herbs
Hawthorn (Crataegus oxyacantha and monogyna)
The flowers and berries of the hawthorn plant have been used in traditional herbal and homeopathic remedies to protect against stroke and to treat chest pain, irregular heartbeat, and heart failure. In addition, studies using rats suggest that the tincture of Crataegus (made from the berries) may be a powerful agent for the removal of LDL from the blood stream. The tincture of hawthorn berries also reduced the production of cholesterol in the liver of rats who were being fed a high-cholesterol diet. Studies to determine if hawthorn will confer the same effects in humans are needed.
Green Tea (Camellia sinensis)
Green tea has been observed to have a variety of beneficial effects, including anticancer and antioxidant effects. The tea has also demonstrated an ability to lower total cholesterol and raise HDL cholesterol in both animals and people. Although an animal study conducted to determine how green tea effects these changes was not conclusive, results from the study suggest that the catechins in green tea may block intestinal absorption of cholesterol and promote its excretion from the body.
Garlic (Allium sativum)
Long hailed for its beneficial effects, a number of studies have found that garlic reduces elevated total cholesterol levels more effectively than placebo. However, the size of the effect in these studies was small, and study limitations make it difficult to draw any firm conclusions. More research with better-designed studies is warranted in order to assess the safety and effectiveness of garlic and to determine the most appropriate dose and form (fresh garlic vs. supplements).
Red clover (Trifolium pratense)
Preliminary studies suggest that chemicals in red clover known as isoflavones may raise HDL levels, especially in menopausal women. Not all studies, however, have shown such positive effects. Further studies are needed before a definitive conclusion can be made.
Bilberry (Vaccinium myrtillus)
Animal studies suggest that bilberry may prevent the oxidation of LDL cholesterol, thereby lessening the risk of this bad form of cholesterol contributing to the development of atherosclerotic plaque in the arteries. Research in people is needed.
Massage and Physical Therapy
While no studies have examined the effect of massage on cholesterol levels, massage has been shown to reduce cortisol (stress-related hormone) levels and to induce relaxation. Massage may therefore have an indirect effect on risk factors that result from or are worsened by stress, such as poor eating habits and obesity, cigarette smoking, or lack of exercise. Lowering cortisol levels may also have a positive effect on cholesterol levels.
Mind/Body Medicine
Stress Reduction
Emotional and social stress increases the risk for heart disease. Stress is thought to promote hardening of the arteries and effective stress reduction techniques can help to reduce high cholesterol levels and other risk factors. In several studies of Transcendental Meditation (TM), significant reductions in total cholesterol levels as well as reductions in blood pressure, obesity, and cigarette smoking were seen after 3 to 11 months of practice. Although TM appears to be one of the more effective methods for relaxation, other methods that may be considered include:
- Progressive muscle relaxation (PMR)
- Biofeedback
- Yoga
- Stress management classes
Ayurveda
Guggulipid (Commiphora mukul)
Guggulipid, a traditional Ayurvedic medication used to treat high cholesterol, is widely used in India and was first recommended as a treatment for hardening of the arteries in 600 BC. It appears to be an effective cholesterol-lowering agent and its healthful effects are thought to be due to its ability to block the production of cholesterol in the liver. In a 4-week study of 61 people who were on a fruit and vegetable-rich diet, half were given guggul supplements of 400 mg three times and the other half received placebo. The guggulipid group had reductions of total cholesterol, LDL, and triglycerides comparable to that seen with conventional cholesterol-lowering drugs while the placebo group had no improvement.
Fenugreek (Trigonella foenum graecum)
Fenugreek is a legume sold as a dried seed. It is cultivated in India and the Middle East, and used as a condiment in foods like curry and in baked goods. In Ayurvedic medicine, spices and herbs are traditionally used to treat a variety of chronic diseases. Fenugreek seeds have been shown to decrease LDL cholesterol and triglycerides, and increase HDL cholesterol levels. These effects appear to result from reduced intestinal absorption of cholesterol, and may be related to the high fiber content of the seed. Consumption of fenugreek may therefore be beneficial in the management of high cholesterol levels.
Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med. 2001;161:813-824.
Al-Habori M, Raman A. Antidiabetic and hypocholesterolemic effects of fenugreek. Phyto Res. 1998;12:233-242.
Anderson JW, Davidson MH, Blonde L, et al. Long-term cholesterol-lowering effects on Psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr. 2000a;71:1433-1438.
Anderson JW, Allgood LD, Lawrence A, et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr. 2000b;71:472-479.
Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. New Engl J Med. 1995; 333:5:276-282.
Arsenian, MA. Carnitine and its derivatives in cardiovascular disease. Progr in Cardiovasc Dis. 1997;40:3:265-286.
Baber R, Bligh PC, Fulcher G, Lieberman D, Nery L, Moreton T. The effect of an Isoflavone dietary supplement (P-081) on serum lipids, forearm bone density & endometrial thickness in post menopausal women [abstract]. Menopause. 1999;6:326.
Binaghi P, Cellina G, Lo Cicero G, et al. Evaluation of the cholesterol-lowering effectiveness of pantethine in women in perimenopausal age [in Italian]. Minerva Med. 1990;81:475-479.
Birketvedt GS, Aaseth J, Florholmen JR, Ryttig K. Long-term effect of fibre supplement and reduced energy intake on body weight and blood lipids in overweight subjects. Acta Medica. 2000;43(4):129-132.
Bonovich K, Colfer H, Davidson M, et al. A multi-center, self-controlled study of cholestin in subjects with elevated cholesterol. Paper presented at: American Heart Association 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; March 1999; Orlando, Fla:Abstract.
Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinal) and fenugreek (Trigonella foenumgraecum) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1997;56(5):379-384.
Bostick RM, Fosdick L, Grandits GA, Grambsch P, Gross M, Louis TA. Effect of calcium supplementation on serum cholesterol and blood pressure. Arch Fam Med. 2000;9:31-39.
Calderon Jr. R, Schneider RH, Alexander CN, Myers HF, Nidich SI, Haney C. Stress, stress reduction and hypercholesterolemia in African Americans: a review. Ethn Dis. 1999;9:451-462.
Castillo-Richmond A, Schneider RH, Alexander CN, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke. 2000;31:568-573.
Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314:112-117.
Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. J Clin Invest. 1996;97:8:1989-1994.
Davidson MH, Maki KC, Kalkowski J, Schaefer EJ, Torri SA, Drennan KB. Effects of docosahexeaenoic acid on serum lipoproteins in patients with combined hyperlipidemia. A randomized, double-blind, placebo-controlled trial. J Am Coll Nutr. 1997;16:3:236-243.
de Logeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99(6):779-785.
Frei B. On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med. 1999;222(3):196-204.
Ginsberg HN, Goldberg IJ. Disorders of Lipoprotein Metabolism. IN: Fauci A, et al. eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 2000: 2138-2149.
Hallikainen MA, Sarkkinen ES, Uusitupa MIJ. Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr. 2000a;130:767-776.
Hallikainen MA, Sarkkinen ES, Gylling H, Erkkila AT, Uusitupa MIJ. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations of hypercholesterolemic subjects on a low-fat diet. Euro J Clin Nutr. 2000b;54:715-725.
HarrisWS. Omega-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-1654S.
Havel R. Dietary supplement or drug? The case of cholestin. Am J Clin Nutr. 1999;69(2)175-176.
Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VLW. Cholesterol-lowering effects of a proprietary Chinese red-yeast rice dietary supplement. Am J Clin Nutr. 1999;69:231-236.
Hosobuchi C, Rutanassee L, Bassin SL, Wong ND. Efficacy of acacia, pectin, and guar gum-based fiber supplementation in the control of hypercholesterolemia. Nutr Res. 1999;19(5):643-649.
Howes JB, Sullivan D, Lai N. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of postmenopausal women with mild to moderate hypercholesterolemia. Atherosclerosis. 2000;152(1):143-147.
Human JA, Ubbink JB, Jerling JJ, et al. The effect of simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolemia. Clin Chim Acta. 1997;263(1):67-77.
Jenkins D, Kendall C, Vidgen E, Agarwal S, Rao AV, Rosenberg RS et al. health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr. 1999;69:395-402.
Keenan JM, Wenz JB, Myers S, Ribsin C, Huang ZQ. Randomized, controlled, crossover trial of oat bran in hypercholesterolemic subjects. J Fam Pract. 1991;33(6):600-608.
Knopp RH, Superko R, Davidson M, et al. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 1999;17(1):18-23.
Kokkinos PF, Fernhall B. Physical activity and high density lipoprotein cholesterol levels. Sports Med. 1999;28(5):307-314.
Kontush A, Schippling S, Spranger T, Beisiegel U. Plasma ubiquinol-10 as a marker for disease: is the assay worthwhile? Biofactors. 1999;9(2-4):225-229.
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al. AHA Scientific Statement: AHA Dietary guidelines Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association. Circulation. 2000;102(18):2284-2299.
Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzare TL. AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation. 2001;103:1823.
Kurowska EM, Spence JD, Jordan J, Wetmore S, Freeman DJ, Piche LA, Serratore P. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr. 2000;72(5):1095-1100.
Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium myrtillus extract on human low density lipoproteins in vitro: initial observations. Fundam Clin Pharmacol. 1997;11(1):35-40.
Lopez-Miranda J, Gomez P, Castro P, et al. Mediterranean diet improves low density lipoproteins' susceptibility to oxidative modifications. Med Clin (Barc) [in Spanish]. 2000;115(10):361-365.
Marz W, Wieland H. HMG-CoA reducatse inhibition: anti-inflammatory effects beyond lipid lowering. Herz. 2000;25(6):117-25.
Mensink RR, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:8:911-919.
Miller AL. Botanical influences on cardiovascular disease. Altern Med Review. 1998;3(6):422-431.
Miyake Y, Shouza A, Nishikawa M, Yonemoto T, Shimizu H, Omoto S, Hayakawa T, Inada M. Effect of treatment with 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung. 1999;49(4):324-329.
Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997;18Suppl:S137-S144.
National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-2497.
National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Circulation. 1994; 89:3:1333-1445.
Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab. 1999;84(3):895-898.
New promensil study – cholesterol benefit. 2000 (October 31). Novogen news and announcements page. Novogen website. Available at: http://www.novogen.com. Accessed March 29, 2001.
Nutrition Committee of the American Heart Association. AHA Dietary Guidelines. Revision 2000: A Statement for Healthcare Professionals. Circulation. 2000; 102:2284-2299.
Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merrit KL, et al. Intensive lifestyle change for reversal of coronary heart disease. JAMA. 1998;280(23):2001-2007.
Plat J, van Onselen ENM, van Heugten MMA, Mensink RP. Effects on serum lipids, lipoproteins, and fat soluble antioxidant concentrations of consumption frequency of margarines and shortenings enriched with plant stanol esters. Euro J Clin Nutr. 2000;54:671-677.
Qin S, Zhang W, Qi P, et al. Elderly patients with primary hyperlipidemia benefited from treatment with a Monacus purpureus rice preparation: a placebo-controlled, double-blind clinical trial. Paper presented at: American Heart Association 39th Annual conference on Cardiovascular Disease Epidemiology and Prevention; March 1999; Orlando, Fla. Abstract.
Raitakari OT, McCredie RJ, Witting P, Griffiths KA, Letter J, Sullivan D, Stocker R, Celermajer DS. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radic Biol Med. 2000;28(7):1100-1105.
Rajendran S, Deepalakshmi PD, Parasakthy K, Devaraj H., Devaraj SN. Effect of tincture of Crataegus on the LDL-receptor activity of hepatic plasma membrane of rats fed an atherogenic diet. Atherosclerosis. 1996;123:235-241.
Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Benneken AM, Berglund L. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis. 1999;143: 427-434.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328(20):1450-1456.
Ripsin CM, Keenan JM, Jacobs Jr. DR, et al. Oat products and lipid lowering: a meta-analysis. JAMA. 1992;267:24:3317-3325.
Shintani TT, Beckham S, Brown AC, O'Connor HK. The Hawaii diet: ad libitum high carbohydrate, low fat multi-cultural diet for the reduction of chronic disease risk factors: obesity, hypertension, hypercholesterolemia, and hyperglycemia. Hawaii Med J. 2991;60(3):69-73.
Singh RB, Niaz MA, Ghosh S. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs and Therapy. 1994;8:659-664.
Sirtori CR, Pazzucconi F, Colombo L, Battistin P, Bondioli A, Descheemaeker K. Double-blind study of high-protein soya milk v. cow's milk to the diet of patients with severe hypercholesterolaemia and resistance to or intolerance of statins. Brit J Nutr. 1999;82:91-96.
Spiller GA, Jenkins DAJ, Boselloo Gates JE, Cragen LN, Bruce B. Nuts and plasma lipids: an almond-based diet lowers LDL-c while Preserving HDL-c. J Am Coll Nutr. 1998;17(3):285-290.
Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328(20):1444-1449.
Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effectsof diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. New Engl J Med. 1998;339(1):12-20.
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996; 347(9004):781-786.
Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. Ann Intern Med. 2000;133(6):420-429.
Sum CF, Winocour PH, Agius L, et al. Does oral L-carnitine alter plasma triglyceride levels in hypertriglyceridemic subjects with or without non-insulin dependent diabetes mellitus. Diabetes Nutr Metab Clin Exp. 1992;5:175-181.
Teixeira SR, Potter SM, Weigel R,Hannam S, Erdman Jr. JW, Hasler CM. Effects of feeding 4 levels of soy Protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr. 2000;71:1077-1084.
Tofler GH, Stec JJ, Stubbe I, Beadle J, Feng D, Lipinska I, Taylor A. The effect of vitamin C supplementation on coagulability and lipid levels in healthy male subjects. Thromb Res. 2000;100(1):35-41.
Van Golde PH, Sloots LM, Vermeulen WP, et al. The role of alcohol in the anti low density lipoprotein oxidation activity of red wine. Atherosclerosis. 1999;147(2):365-370.
Verhaar MC, Wever RM, Kastelein JJ, et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia. Circulation. 1999;100(4):335-338.
Villalobos MA, De La Cruz JP, Martin-Romero M, Carmona JA, Smith-Agreda JM, Sanchez de la Cueta F. Effect of dietary supplementation with evening primrose oil on vascular thrombogenesis in hyperlipidemic rabbits. Thromb Haemost. 1998;80:696-701.
Williams JC, Forster LA, Tull SP, Wong M, Bevan RJ, Ferns GAA. Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia. M J Exp Path. 1997;78:259-266.
Wang J, Lu Z, Chi J, et al. Multicenter clinical trial of serum lipid-lowering effects of a Monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Curr Ther Res. 1997;58(12):964-978.
Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998;68(suppl):1385S-1389S.
Yang TTC, Koo MWI. Chinese green tea lowers cholesterol level through an increase in fecal lipid excreiton. Life Sciences. 1999:66:5:411-423.
Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr. 1999;69:632-646.
Zambón D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. Ann Intern Med. 2000;132:538-546.